Next Gen Biotech

Encicarb 500mg injection contains the active substance Ferric carboxymaltose. It belongs to the group of medications called iron replacement products. It is used to treat iron-deficiency anemia (decreased RBC due to lower levels of iron in the body) in adults and pediatric patients who cannot tolerate oral iron or when oral iron supplements are ineffective. It is also indicated to treat iron deficiency anemia in adults with chronic kidney disease who are not on dialysis. This medicine is not recommended for pediatric patients less than one year of age. 

Do not take this medicine if you are allergic to ferric carboxymaltose or any of the other ingredients of this medicine. Do not receive Encicarb 500mg injection if you have anemia that is not caused by iron deficiency, an iron overload (too much iron in the body), or difficulties in using iron. Inform your physician if you have rheumatoid arthritis, severe asthma, eczema, infection, liver disorders, or low phosphate levels in the blood. Incorrect administration of this injection may cause irritation and long-lasting discoloration at the administration site.  

Inform your physician if you are pregnant or breastfeeding before initiating the treatment with Encicarb 500mg injection. The most common side effects are nausea, hypertension, flushing, injection site reactions, skin reactions, vomiting, and dizziness. Tell your physician if you have experienced serious allergic (hypersensitive) reactions to other injectable iron preparations.